greeksoup/ stock research
Stock research / United States / RDY / Year to 31 March 2026

Dr. Reddy’s Laboratories Limited (RDY) annual results, year to 31 March 2026: revenue INR 335,933 million, from the 20-F

Dr. Reddy’s Laboratories Limited files a 20-F with the SEC once a year, in Indian rupees. In the year to 31 March 2026 it reported revenue of INR 335,933 million ($3.8 billion at the year's average rate), up 3.2% on the year before. Its profit attributable to shareholders was INR 42,850 million, down 24.2%, and diluted earnings per share INR 51.42.

Revenue
INR 335,933 million
+3.2% on the year
FY2019FY2026
Operating margin
15.0%
22.1% a year earlier
FY2019FY2026
Net income
INR 42,850 million
-24.2% on the year
FY2019FY2026
Diluted EPS
INR 51.42
-24.1% on the year
FY2019FY2026

this yearthe year beforeIn Indian rupees as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toMar 2025Mar 2026
Revenue325,535335,933
Cost of sales135,107158,669
Gross profit190,428177,264
Research and development27,38024,058
Selling, general and administrative93,870106,763
Operating profit71,84350,551
Finance costs2,8293,738
Profit before tax76,78454,817
Income tax19,53912,351
Profit for the year57,24542,466
Profit attributable to shareholders56,54442,850
Filing20-F20-F
INR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toMar 2025Mar 2026
Diluted EPS67.7851.42
Basic EPS67.8851.48
Filing20-F20-F

INR per ordinary share, as filed.

Cash flow

Year toMar 2025Mar 2026
Cash from operations46,42856,755
Purchase of property, plant and equipment27,50423,326
Free cash flow18,92433,429
Cash from investing-58,077-65,513
Cash from financing18,9118,290
Depreciation and amortisation17,05820,605
Dividends paid6,6626,659
Filing20-F20-F

INR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toMar 2025Mar 2026
Funded by
Equity attributable to shareholders333,388377,063
Non-controlling interests3,7783,394
Borrowings, as filed46,76677,341
Lease liabilitiesn/a5,436
Other liabilities109,057116,112
Total equity and liabilities492,989579,346
Owned
Property, plant and equipment97,761115,930
Goodwill11,81012,893
Other intangible assets96,803105,059
Cash and cash equivalents14,65415,368
Trade and other receivables90,420101,219
Inventories71,08576,531
Other assets110,456152,346
Total assets492,989579,346
Filing20-F20-F

INR million, at each fiscal year end.

Ratios on the filed lines

Year toMar 2025Mar 2026
Gross margin58.5%52.8%
Operating margin22.1%15.0%
Net margin17.4%12.8%
Free cash flow margin5.8%10.0%
Return on year-end equity17.0%11.4%
Effective tax rate25.4%22.5%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 March 2026, filed 29 May 2026: the filing. The figures are in Indian rupees as filed.